Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram

Annals of Surgery

Volumn 251, Issue 4, 2010, Pages 640-646

  Strong, Vivian E ^a   Song, Kyo Young ^b   Park, Cho Hyun ^b   Jacks, Lindsay M ^c   Gonen, Mithat ^c   Shah, Manish ^a   Coit, Daniel G ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b The Catholic University of Korea   (South Korea)

^c Division of Biostatistics and Epidemiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HUMAN; INTERMETHOD COMPARISON; KOREA; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; TUMOR LOCALIZATION; UNITED STATES; VALIDATION STUDY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMANS; KOREA; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; STOMACH NEOPLASMS; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 77950860026     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181d3d29b     Document Type: Article

References (36)

1. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
2. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998;90:150-155.
3. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarci-noma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104:510-513. (Pubitemid 23033424)
4. Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg. 2000;232:362-371.
5. Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg. 2000;66:821-826.
6. Noguchi Y, Imada T, Matsumoto A, et al. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer. 1989;64:2053-2062. (Pubitemid 19280403)
7. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet. 1997; 349:1725-1729. (Pubitemid 27252671)
8. Schwarz RE, Zagala-Nevarez K. Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol. 2002;28:214-219. (Pubitemid 35023670)
9. Bollschweiler E, Boettcher K, Hoelscher AH, et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer. 1993;71:2918-2925. (Pubitemid 23145517)
10. Yao JC, Schnirer II, Reddy S, et al. Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer. 2002;5:208-212.
11. Kattan MW, Karpeh MS, Mazumdar M, et al. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647-3650.
12. Peeters KC, Kattan MW, Hartgrink HH, et al. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer. 2005;103:702-707.
13. Koc M, Dizen H, Ozalp N, et al. External validation of a US-derived nomogram that predicts individual survival after gastric cancer resection. Langenbecks Arch Surg. 2008;394:755-756.
14. Peng L, Fine JP. Regression modeling of semicompeting risks data. Biometrics. 2007;63:96-108.
15. Novotny AR, Schuhmacher C, Busch R, et al. Predicting individual survival after gastric cancer resection: validation of a U. S.-derived nomogram at a single high-volume center in Europe.Ann Surg. 2006;243:74-81.
16. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11-20.
17. Roder JD, Bonenkamp JJ, Craven J, et al. Lymphadenectomy for gastric cancer in clinical trials: update. World J Surg. 1995;19:546-553.
18. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995; 4:85-92.
19. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999; 130:883-890.
20. Lagergren J, Bergstrom R, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer. 2000;85:340-346.
21. Dent DM. Cancer surgery: why some survival benefits may be artifactual. Br J Surg. 1998;85:433-434.
22. Siewert JR, Bottcher K, Roder JD, et al. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993;80:1015-1018.
23. Shiu MH, Moore E, Sanders M, et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma. A retrospective multi-variate analysis. Arch Surg. 1987;122:1347-1351.
24. Steinberg ML, Hwang BJ, Tang L, et al. E-cadherin gene alterations in gastric cancers in different ethnic populations. Ethn Dis. 2008;18(2 suppl 2):S2-S4.
25. Zhou Y, Li N, Zhuang W, et al. Interleukin-10-1082 promoter polymorphism associated with gastric cancer among Asians. Eur J Cancer. 2008;44:2648-2654.
26. Zhang J, Dou C, Song Y, et al. Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis. J Hum Genet. 2008;53:479-489.
27. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608.
28. Tanaka K, Miyashiro I, Yano M, et al. Accumulation of excess visceral fat is a risk factor for pancreatic fistula formation after total gastrectomy. Ann Surg Oncol. 2009;16:1520-1525.
29. Vin Y, Sima CS, Getrajdman GI, et al. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207: 490-498.
30. Sledzianowski JF, Duffas JP, Muscari F, et al. Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. Surgery. 2005;137: 180-185.
31. Kang CM, Kim DH, Choi GH, et al. Detrimental effect of postoperative complications on oncologic efficacy of r0 pancreatectomy in ductal adeno-carcinoma of the pancreas. J Gastrointest Surg. 2009;13:907-914.
32. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocar-cinoma. Ann Surg. 2007;246:52-60.
33. Howard TJ, Krug JE, Yu J, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg. 2006;10: 1338-1345.
34. Verdecchia A, Mariotto A, Gatta G, et al. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer. 2003;39:1603-1609.
35. Gill S, Shah A, Le N, et al. Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol. 2003;21:2070-2076.
36. Redaniel MT, Laudico A, Mirasol-Lumague MR, et al. Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States. Br J Cancer. 2009;100:858-862.